Physician

Arpana Shah, MD

According to 2025 Medicare claims, Arpana Shah, MD (NPI: 1134148075) practices dermatology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is SHAH DERMATOLOGY LLC (NPI: 1760873194; TIN: 453636575) and primary practice location at 20622-3188.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,291 traditional Medicare patients, billed 6,036 HCPCS/CPT codes, and received $345,745 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,098 prescription claims across 345 beneficiaries totaling $716,272 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 11 records totaling $313. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $192,769 to $345,745. Similarly, Part D prescription costs have risen steadily, from $130,714 to $716,272. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$173K$346K2015 Medicare payment: $192,769 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $226,545 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $222,405 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $241,559 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $286,640 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $257,308 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $340,053 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $312,889 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $325,107 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $345,745 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158644,160$192,769
20169515,004$226,545
20179454,755$222,405
20181,0524,934$241,559
20191,1616,014$286,640
20201,0695,319$257,308
20211,1756,456$340,053
20221,1836,348$312,889
20231,2446,291$325,107
20241,2916,036$345,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$358K$716K2015 Drug cost: $130,714 (USD; Tot_Drug_Cst)2016 Drug cost: $117,648 (USD; Tot_Drug_Cst)2017 Drug cost: $155,604 (USD; Tot_Drug_Cst)2018 Drug cost: $219,311 (USD; Tot_Drug_Cst)2019 Drug cost: $167,211 (USD; Tot_Drug_Cst)2020 Drug cost: $161,546 (USD; Tot_Drug_Cst)2021 Drug cost: $213,983 (USD; Tot_Drug_Cst)2022 Drug cost: $176,802 (USD; Tot_Drug_Cst)2023 Drug cost: $334,236 (USD; Tot_Drug_Cst)2024 Drug cost: $716,272 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015142329$130,714
2016144453$117,648
2017146407$155,604
2018159507$219,311
2019188621$167,211
2020195635$161,546
2021199617$213,983
2022235593$176,802
2023257709$334,236
20243451,098$716,272

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more7551,096$80
17110Destruction of skin growth, 1-14 growths373431$72
11102Biopsy of related skin growth, first growth281333$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more517728$54
17000Destruction of precancer skin growth, 1 growth320426$35

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab652,632$358,921
Betamethasone DipropionateBetamethasone Dipropionate1595,155$5,832
Clobetasol PropionateClobetasol Propionate662,090$5,427
TretinoinTretinoin31900$2,796
KetoconazoleKetoconazole1404,646$2,781

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$313E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Arpana Shah, MD?

Tedicare shows public-source Medicare data for Arpana Shah, MD (NPI 1134148075), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arpana Shah, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arpana Shah, MD?

Arpana Shah, MD is linked to SHAH DERMATOLOGY LLC (billing NPI 1760873194) in the available physician profile data.

Does Arpana Shah, MD have Open Payments data?

Arpana Shah, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.